- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 16 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 8 residues within 4Å:- Chain A: R.85, S.99, R.192, F.284, A.285
- Ligands: HEM.1, EDO.11, EDO.12
Ligand excluded by PLIPGOL.3: 6 residues within 4Å:- Chain A: P.21, S.32, F.40, E.43, K.47, Y.48
Ligand excluded by PLIPGOL.4: 7 residues within 4Å:- Chain A: P.21, T.22, L.24, N.29, L.31, S.32
- Ligands: EDO.13
Ligand excluded by PLIPGOL.5: 11 residues within 4Å:- Chain A: G.36, F.37, C.38, M.351, L.457, S.458, G.460, G.461, L.462, L.463, Q.464
Ligand excluded by PLIPGOL.6: 6 residues within 4Å:- Chain A: I.30, L.31, Y.33, H.34, L.196, L.201
Ligand excluded by PLIPGOL.7: 5 residues within 4Å:- Chain A: K.310, E.334, Y.335, M.338, E.397
Ligand excluded by PLIPGOL.8: 4 residues within 4Å:- Chain A: D.360, V.361, E.362, F.367
Ligand excluded by PLIPGOL.9: 5 residues within 4Å:- Chain A: P.305, Q.308, Q.309, Q.312, S.444
Ligand excluded by PLIPGOL.23: 8 residues within 4Å:- Chain B: R.85, S.99, R.192, F.284, A.285
- Ligands: HEM.22, EDO.32, EDO.33
Ligand excluded by PLIPGOL.24: 6 residues within 4Å:- Chain B: P.21, S.32, F.40, E.43, K.47, Y.48
Ligand excluded by PLIPGOL.25: 7 residues within 4Å:- Chain B: P.21, T.22, L.24, N.29, L.31, S.32
- Ligands: EDO.34
Ligand excluded by PLIPGOL.26: 11 residues within 4Å:- Chain B: G.36, F.37, C.38, M.351, L.457, S.458, G.460, G.461, L.462, L.463, Q.464
Ligand excluded by PLIPGOL.27: 6 residues within 4Å:- Chain B: I.30, L.31, Y.33, H.34, L.196, L.201
Ligand excluded by PLIPGOL.28: 5 residues within 4Å:- Chain B: K.310, E.334, Y.335, M.338, E.397
Ligand excluded by PLIPGOL.29: 4 residues within 4Å:- Chain B: D.360, V.361, E.362, F.367
Ligand excluded by PLIPGOL.30: 5 residues within 4Å:- Chain B: P.305, Q.308, Q.309, Q.312, S.444
Ligand excluded by PLIP- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.10: 5 residues within 4Å:- Chain A: F.13, I.18, G.20, T.22, Y.55
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: R.192, T.289, A.350
- Ligands: HEM.1, GOL.2
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: S.99, I.100, R.192, F.193, I.281, F.284
- Ligands: GOL.2
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: L.31, S.32
- Ligands: GOL.4
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: Y.387, W.388, T.389, R.398
- Ligands: EDO.18
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: K.153, G.157, L.191, Y.287, S.291
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain A: Q.259, S.261
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: L.331, E.334, D.337, K.433
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain A: Y.387, W.388, N.406, I.407, D.408, I.411
- Ligands: EDO.14
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain A: I.164, T.167, S.168, F.251, F.282, G.286
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain A: D.56, G.57, Q.58, Q.59, T.204, P.207
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain A: F.347, R.383, L.457
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain B: F.13, I.18, G.20, T.22, Y.55
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain B: R.192, T.289, A.350
- Ligands: HEM.22, GOL.23
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain B: S.99, I.100, R.192, F.193, I.281, F.284
- Ligands: GOL.23
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain B: L.31, S.32
- Ligands: GOL.25
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain B: Y.387, W.388, T.389, R.398
- Ligands: EDO.39
Ligand excluded by PLIPEDO.36: 5 residues within 4Å:- Chain B: K.153, G.157, L.191, Y.287, S.291
Ligand excluded by PLIPEDO.37: 2 residues within 4Å:- Chain B: Q.259, S.261
Ligand excluded by PLIPEDO.38: 4 residues within 4Å:- Chain B: L.331, E.334, D.337, K.433
Ligand excluded by PLIPEDO.39: 7 residues within 4Å:- Chain B: Y.387, W.388, N.406, I.407, D.408, I.411
- Ligands: EDO.35
Ligand excluded by PLIPEDO.40: 6 residues within 4Å:- Chain B: I.164, T.167, S.168, F.251, F.282, G.286
Ligand excluded by PLIPEDO.41: 6 residues within 4Å:- Chain B: D.56, G.57, Q.58, Q.59, T.204, P.207
Ligand excluded by PLIPEDO.42: 3 residues within 4Å:- Chain B: F.347, R.383, L.457
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sevrioukova, I.F., High-Level Production and Properties of the Cysteine-Depleted Cytochrome P450 3A4. Biochemistry (2017)
- Release Date
- 2017-05-31
- Peptides
- Cytochrome P450 3A4: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
SMTL ID : 5vcc.1 (1 other biounit)
Crystal structure of human CYP3A4 bound to glycerol
Cytochrome P450 3A4
Toggle Identical (AB)Related Entries With Identical Sequence
3tjs.1 | 3ua1.1 | 4d78.1 | 4d7d.1 | 4i3q.1 | 4i3q.2 | 4i4g.1 | 4i4g.2 | 4i4h.1 | 4i4h.2 | 4k9t.1 | 4k9u.1 | 4k9v.1 | 4k9w.1 | 4k9w.2 | 4k9w.3 | 4k9w.4 | 4k9x.1 | 5a1p.1 | 5a1r.1 | 5g5j.1 | 5te8.1 | 5vc0.1 | 5vc0.2 | 5vcc.2 | 6bcz.1 | 6bd5.1 | 6bd6.1 | 6bd7.1 | 6bd8.1 more...less...6bdh.1 | 6bdi.1 | 6bdk.1 | 6bdm.1 | 6da2.1 | 6da3.1 | 6da5.1 | 6da8.1 | 6daa.1 | 6dab.1 | 6dac.1 | 6dag.1 | 6daj.1 | 6dal.1 | 6ma6.1 | 6ma6.2 | 6ma8.1 | 6oo9.1 | 6ooa.1 | 6oob.1 | 6une.1 | 6une.2 | 6ung.1 | 6ung.2 | 6unh.1 | 6unh.2 | 6uni.1 | 6uni.2 | 6unj.1 | 6unj.2 | 6unj.3 | 6unk.1 | 6unk.2 | 6unl.1 | 6unl.2 | 6unm.1 | 6unm.2 | 6unm.3 | 7ks8.1 | 7ksa.1 | 7kvh.1 | 7kvi.1 | 7kvj.1 | 7kvm.1 | 7kvn.1 | 7kvo.1 | 7kvp.1 | 7kvq.1 | 7uay.1 | 7uaz.1 | 7uf9.1 | 7ufa.1 | 7ufb.1 | 7ufc.1 | 7ufd.1 | 8dyc.1 | 8ewd.1 | 8ewe.1 | 8ewl.1 | 8ewm.1 | 8ewn.1 | 8ewp.1 | 8ewq.1 | 8ewr.1 | 8ews.1 | 8exb.1 | 8so1.1 | 8so2.1 | 9bbb.1